ArticleNature communications2026
On-oligonucleotide olefin metathesis in water.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Genetically-encoded libraries represent a breakthrough in the large-scale screening of chemical matter. Within such technologies, encoded libraries of synthetic macrocycles generated by ring-closing metathesis hold significant potential to address conventionally undruggable targets. To date, however, the mutual incompatibility of olefin metathesis catalysts and nucleic acids, exacerbated by short catalyst lifetimes in water, has limited advance. Described herein is the synthesis of nucleic acid-tagged macrocycles via ring-closing metathesis (RCM) in neat water, using an anionic, water-soluble ruthenium catalyst designed for this purpose. The ruthenium complex exhibits high compatibility with different oligonucleotide tags, including DNA and RNA oligomers and a chemically-stabilized DNA congener, furnishing the target macrocycles with useful conversions and recovery of the nucleic acid. This advance paves the way for uptake of ring-closing metathesis in water for encoded-library technologies, and for broader applications of nucleic acids, potentially including RNA-oligonucleotide drugs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.